Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug/Agent Toxicity by Tissue/Organ”

119 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 119 results

Testing effectiveness (Phase 2)UnknownNCT01965275
What this trial is testing

High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs

Who this might be right for
Self EfficacyDrug Toxicity
Anhui Medical University 20
Post-approval studies (Phase 4)Study completedNCT03461445
What this trial is testing

Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant Recipients

Who this might be right for
Kidney Transplant; ComplicationsToxicityDrug Toxicity+1 more
University of California, Davis 64
Not applicableUnknownNCT03481192
What this trial is testing

Voluntary Drug Poisoning by Psychoactive Molecules: Identify Cognitive Markers

Who this might be right for
SuicideDrug Poisoning
University Hospital, Toulouse 103
Testing effectiveness (Phase 2)Active Not RecruitingNCT04305145
What this trial is testing

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVSkin Cancer Stage III+4 more
Massachusetts General Hospital 42
Large-scale testing (Phase 3)Study completedNCT00296036
What this trial is testing

Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 137
Not applicableNot Yet RecruitingNCT06837571
What this trial is testing

Methadone Dose Monitoring With a Remote Medication Monitor

Who this might be right for
Methadone ToxicityMethadone OverdosePain, Chronic+2 more
Cari Health Inc. 30
Not applicableLooking for participantsNCT05981573
What this trial is testing

Assessment of Methadone Dose Taken

Who this might be right for
Methadone ToxicityMethadone OverdosePain, Chronic+2 more
Cari Health Inc. 30
Large-scale testing (Phase 3)Study completedNCT00003600
What this trial is testing

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Who this might be right for
AnemiaBreast CancerChronic Myeloproliferative Disorders+8 more
Alliance for Clinical Trials in Oncology 344
Post-approval studies (Phase 4)Study completedNCT05237492
What this trial is testing

The Influence of Tramadol on Platelet Function

Who this might be right for
Drug ToxicityPlatelet DysfunctionClotting Disorder
Medical University of Graz 33
Post-approval studies (Phase 4)Study completedNCT04070469
What this trial is testing

Plasma Concentrations of Amoxicillin Administered in High-doses During the First Week of Treatment (MAX-AMOX)

Who this might be right for
Infection, Bacterial
University Hospital, Clermont-Ferrand 142
Early research (Phase 1)UnknownNCT00024310
What this trial is testing

Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
Post-approval studies (Phase 4)UnknownNCT01102335
What this trial is testing

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy

Who this might be right for
Hepatocellular Carcinoma
Fudan University 80
Not applicableStudy completedNCT01614080
What this trial is testing

Outcome of Patients Treated by iv Rt-PA for Cerebral Ischaemia According to the Ratio Sc-tPA/Tc-tPA

Who this might be right for
Stroke, AcuteDrug Toxicity
University Hospital, Lille 700
Early research (Phase 1)Study completedNCT00491595
What this trial is testing

Phase I Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women

Who this might be right for
Drug Toxicity
University of North Carolina 36
Not applicableUnknownNCT02439658
What this trial is testing

Genetics of QT Prolongation With Antiarrhythmics

Who this might be right for
Long QT SyndromeDrug Toxicity
Massachusetts General Hospital 1,000
Not applicableStudy completedNCT04275024
What this trial is testing

Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients

Who this might be right for
Mesenchymal Stromal CellsPsoriasisDrug Effect+1 more
Guangdong Provincial Hospital of Traditional Chinese Medicine 8
Not applicableUnknownNCT05851222
What this trial is testing

A Big Data Approach to Predict NEOnatal Acute Kidney Injury in Newborns expoSed to nephroTOxic Drugs (NeoAKI STOP)

Who this might be right for
Acute Kidney InjuryDrug UseDrug Interaction+5 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 4,200
Large-scale testing (Phase 3)Study completedNCT00003313
What this trial is testing

Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung CancerOral Complications+1 more
Radiation Therapy Oncology Group 243
Testing effectiveness (Phase 2)Study completedNCT00003089
What this trial is testing

Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Large-scale testing (Phase 3)Study completedNCT00075868
What this trial is testing

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

Who this might be right for
Anal CancerColorectal CancerDrug/Agent Toxicity by Tissue/Organ+1 more
Radiation Therapy Oncology Group 233
Load More Results